These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17157396)

  • 1. Circulating angiogenic cytokines and stem cells in patients with severe chronic ischemic heart disease--indicators of myocardial ischemic burden?
    Ripa RS; Wang Y; Goetze JP; Jørgensen E; Johnsen HE; Tägil K; Hesse B; Kastrup J
    Int J Cardiol; 2007 Aug; 120(2):181-7. PubMed ID: 17157396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autotransplantation of mesenchymal stromal cells from bone-marrow to heart in patients with severe stable coronary artery disease and refractory angina--final 3-year follow-up.
    Mathiasen AB; Haack-Sørensen M; Jørgensen E; Kastrup J
    Int J Cardiol; 2013 Dec; 170(2):246-51. PubMed ID: 24211066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Circulating endothelial progenitor cells and vascular endothelial dysfunction].
    Ruda MM; Aref'eva TI; Tripoten' MI; Balakhonova TV; Parfenova EV; Karpov IuA
    Ross Fiziol Zh Im I M Sechenova; 2009 Jun; 95(6):545-62. PubMed ID: 19639879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between the frequency of CD34⁺ bone marrow derived circulating progenitor cells and the number of diseased coronary arteries in patients with myocardial ischemia and diabetes.
    Bozdag-Turan I; Turan RG; Turan CH; Ludovicy S; Akin I; Kische S; Arsoy NS; Schneider H; Ortak J; Rehders T; Hermann T; Paranskaya L; Kohlschein P; Bastian M; Ulus AT; Sahin K; Ince H; Nienaber CA
    Cardiovasc Diabetol; 2011 Nov; 10():107. PubMed ID: 22118372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial progenitor cells, atheroma burden and clinical outcome in patients with coronary artery disease.
    Padfield GJ; Tura-Ceide O; Freyer E; Barclay GR; Turner M; Newby DE; Mills NL
    Heart; 2013 Jun; 99(11):791-8. PubMed ID: 23390050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study.
    Povsic TJ; Junge C; Nada A; Schatz RA; Harrington RA; Davidson CJ; Fortuin FD; Kereiakes DJ; Mendelsohn FO; Sherman W; Schaer GL; White CJ; Stewart D; Story K; Losordo DW; Henry TD
    Am Heart J; 2013 Jun; 165(6):854-861.e2. PubMed ID: 23708155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction.
    Wojakowski W; Tendera M; Michałowska A; Majka M; Kucia M; Maślankiewicz K; Wyderka R; Ochała A; Ratajczak MZ
    Circulation; 2004 Nov; 110(20):3213-20. PubMed ID: 15533859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte colony stimulating factor in chronic angina to stimulate neovascularisation: a placebo controlled crossover trial.
    Chih S; Macdonald PS; McCrohon JA; Ma D; Moore J; Feneley MP; Law M; Kovacic JC; Graham RM
    Heart; 2012 Feb; 98(4):282-90. PubMed ID: 22115984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemia-related changes in circulating stem and progenitor cells and associated clinical characteristics in peripheral artery disease.
    Saber R; Liu K; Ferrucci L; Criqui MH; Zhao L; Tian L; Guralnik JM; Liao Y; Domanchuk K; Kibbe MR; Green D; Perlman H; McDermott MM
    Vasc Med; 2015 Dec; 20(6):534-43. PubMed ID: 26324152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exercise-induced ischemia.
    Adams V; Lenk K; Linke A; Lenz D; Erbs S; Sandri M; Tarnok A; Gielen S; Emmrich F; Schuler G; Hambrecht R
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):684-90. PubMed ID: 14988094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating endothelial progenitor cells as markers for severity of ischemic chronic heart failure.
    Berezin AE; Kremzer AA
    J Card Fail; 2014 Jun; 20(6):438-47. PubMed ID: 24594088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Wang Y; Johnsen HE; Mortensen S; Bindslev L; Ripa RS; Haack-Sørensen M; Jørgensen E; Fang W; Kastrup J
    Heart; 2006 Jun; 92(6):768-74. PubMed ID: 16251230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating apoptotic progenitor cells: a novel biomarker in patients with acute coronary syndromes.
    Schwartzenberg S; Deutsch V; Maysel-Auslender S; Kissil S; Keren G; George J
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):e27-31. PubMed ID: 17332488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of circulating VEGFR2+ Bone marrow-derived progenitor cells correlate with metastatic disease in patients with pediatric solid malignancies.
    Taylor M; Rössler J; Geoerger B; Laplanche A; Hartmann O; Vassal G; Farace F
    Clin Cancer Res; 2009 Jul; 15(14):4561-71. PubMed ID: 19605404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stem cell mobilization after coronary artery bypass grafting].
    Gaspardone A; De Fabritiis P; Scaffa R; Nardi P; Palombi F; Versaci F; Chiariello L
    Ital Heart J Suppl; 2004 Jan; 5(1):23-8. PubMed ID: 15253141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between circulating endothelial progenitor cells and insulin resistance in non-diabetic patients with ischemic chronic heart failure.
    Berezin AE; Kremzer AA
    Diabetes Metab Syndr; 2014; 8(3):138-44. PubMed ID: 25082501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary hyperparathyroidism is associated with increased circulating bone marrow-derived progenitor cells.
    Brunner S; Theiss HD; Murr A; Negele T; Franz WM
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1670-5. PubMed ID: 17911347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased levels of angiogenic growth factors in intracranial atherosclerotic disease despite severity-related increase in endothelial progenitor cell counts.
    Massot A; Navarro-Sobrino M; Penalba A; Arenillas JF; Giralt D; Ribó M; Molina CA; Alvarez-Sabín J; Montaner J; Rosell A
    Cerebrovasc Dis; 2013; 35(1):81-8. PubMed ID: 23429001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change of plasma leukotriene C4 during myocardial ischemia in humans.
    Takase B; Kurita A; Maruyama T; Uehata A; Nishioka T; Mizuno K; Nakamura H; Katsura K; Kanda Y
    Clin Cardiol; 1996 Mar; 19(3):198-204. PubMed ID: 8674256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction.
    Leone AM; Rutella S; Bonanno G; Contemi AM; de Ritis DG; Giannico MB; Rebuzzi AG; Leone G; Crea F
    Int J Cardiol; 2006 Aug; 111(2):202-8. PubMed ID: 16051386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.